These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 21095183)
21. A pepducin designed to modulate P2Y2R function interacts with FPR2 in human neutrophils and transfers ATP to an NADPH-oxidase-activating ligand through a receptor cross-talk mechanism. Gabl M; Holdfeldt A; Winther M; Oprea T; Bylund J; Dahlgren C; Forsman H Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1228-37. PubMed ID: 26996596 [TBL] [Abstract][Full Text] [Related]
22. Desensitization of formyl peptide receptors is abolished in calcium ionophore-primed neutrophils: an association of the ligand-receptor complex to the cytoskeleton is not required for a rapid termination of the NADPH-oxidase response. Liu L; Harbecke O; Elwing H; Follin P; Karlsson A; Dahlgren C J Immunol; 1998 Mar; 160(5):2463-8. PubMed ID: 9498791 [TBL] [Abstract][Full Text] [Related]
23. What formyl peptide receptors, if any, are triggered by compound 43 and lipoxin A4? Forsman H; Önnheim K; Andreasson E; Dahlgren C Scand J Immunol; 2011 Sep; 74(3):227-234. PubMed ID: 21535079 [TBL] [Abstract][Full Text] [Related]
24. Peptide length and folding state govern the capacity of staphylococcal β-type phenol-soluble modulins to activate human formyl-peptide receptors 1 or 2. Kretschmer D; Rautenberg M; Linke D; Peschel A J Leukoc Biol; 2015 Apr; 97(4):689-97. PubMed ID: 25724390 [TBL] [Abstract][Full Text] [Related]
25. The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1. El Zein N; Badran B; Sariban E Cell Calcium; 2008 Mar; 43(3):270-84. PubMed ID: 17651798 [TBL] [Abstract][Full Text] [Related]
26. A methodological approach to studies of desensitization of the formyl peptide receptor: Role of the read out system, reactive oxygen species and the specific agonist used to trigger neutrophils. Karlsson J; Bylund J; Movitz C; Björkman L; Forsman H; Dahlgren C J Immunol Methods; 2010 Jan; 352(1-2):45-53. PubMed ID: 19891970 [TBL] [Abstract][Full Text] [Related]
27. A neutrophil inhibitory pepducin derived from FPR1 expected to target FPR1 signaling hijacks the closely related FPR2 instead. Winther M; Gabl M; Welin A; Dahlgren C; Forsman H FEBS Lett; 2015 Jul; 589(15):1832-9. PubMed ID: 26071379 [TBL] [Abstract][Full Text] [Related]
28. Prevention of macrophage adhesion molecule-1 (Mac-1)-dependent neutrophil firm adhesion by taxifolin through impairment of protein kinase-dependent NADPH oxidase activation and antagonism of G protein-mediated calcium influx. Wang YH; Wang WY; Liao JF; Chen CF; Hou YC; Liou KT; Chou YC; Tien JH; Shen YC Biochem Pharmacol; 2004 Jun; 67(12):2251-62. PubMed ID: 15163556 [TBL] [Abstract][Full Text] [Related]
29. The FPR2-induced rise in cytosolic calcium in human neutrophils relies on an emptying of intracellular calcium stores and is inhibited by a gelsolin-derived PIP2-binding peptide. Forsman H; Dahlgren C BMC Cell Biol; 2010 Jul; 11():52. PubMed ID: 20602801 [TBL] [Abstract][Full Text] [Related]
30. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. Hu JY; Le Y; Gong W; Dunlop NM; Gao JL; Murphy PM; Wang JM J Leukoc Biol; 2001 Jul; 70(1):155-61. PubMed ID: 11435499 [TBL] [Abstract][Full Text] [Related]
31. Formyl peptide receptors are coupled to multiple mitogen-activated protein kinase cascades by distinct signal transduction pathways: role in activation of reduced nicotinamide adenine dinucleotide oxidase. Rane MJ; Carrithers SL; Arthur JM; Klein JB; McLeish KR J Immunol; 1997 Nov; 159(10):5070-8. PubMed ID: 9366435 [TBL] [Abstract][Full Text] [Related]
32. The peptide Trp-Lys-Tyr-Met-Val-D-Met activates neutrophils through the formyl peptide receptor only when signaling through the formylpeptide receptor like 1 is blocked. A receptor switch with implications for signal transduction studies with inhibitors and receptor antagonists. Karlsson J; Fu H; Boulay F; Bylund J; Dahlgren C Biochem Pharmacol; 2006 May; 71(10):1488-96. PubMed ID: 16549058 [TBL] [Abstract][Full Text] [Related]
33. Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1. Liu FC; Yu HP; Syu YT; Fang JY; Lin CF; Chang SH; Lee YT; Hwang TL Sci Rep; 2017 Jul; 7(1):6718. PubMed ID: 28751674 [TBL] [Abstract][Full Text] [Related]
34. Gastrin-releasing peptide/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors. Schepetkin IA; Kirpotina LN; Khlebnikov AI; Jutila MA; Quinn MT Mol Pharmacol; 2011 Jan; 79(1):77-90. PubMed ID: 20943772 [TBL] [Abstract][Full Text] [Related]
35. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. Rabiet MJ; Huet E; Boulay F Eur J Immunol; 2005 Aug; 35(8):2486-95. PubMed ID: 16025565 [TBL] [Abstract][Full Text] [Related]
36. Structural characterization and inhibitory profile of formyl peptide receptor 2 selective peptides descending from a PIP2-binding domain of gelsolin. Forsman H; Andréasson E; Karlsson J; Boulay F; Rabiet MJ; Dahlgren C J Immunol; 2012 Jul; 189(2):629-37. PubMed ID: 22706076 [TBL] [Abstract][Full Text] [Related]
37. FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils. Gabl M; Holdfeldt A; Sundqvist M; Lomei J; Dahlgren C; Forsman H Biochem Pharmacol; 2017 Dec; 145():114-122. PubMed ID: 28855087 [TBL] [Abstract][Full Text] [Related]
38. Characterization of FcalphaR-triggered Ca(2+) signals: role in neutrophil NADPH oxidase activation. Lang ML; Kerr MA Biochem Biophys Res Commun; 2000 Sep; 276(2):749-55. PubMed ID: 11027542 [TBL] [Abstract][Full Text] [Related]